SanofiSNYNF
13F holders, Q2 2026 (June 30)2holders
0new positions
0sold out
$85.76avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Sanofi (SNYNF) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($2.5M) and GAMMA Investing LLC ($5K).
- Company
- Sanofi
- CUSIP
- F5548N101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 564 shares bought and 248 shares sold, net +316 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.12% | Add +2.0% | 29,339 | $2.5M |
| GAMMA Investing LLC | 0.00% | Reduce -81.0% | 58 | $5K |
"% of holder's portfolio" is SNYNF's weight in each manager's 13F, not the share of Sanofi the manager owns.